{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:43:01Z","timestamp":1773344581041,"version":"3.50.1"},"reference-count":66,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,7,5]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Tungiasis (sand flea disease or jigger infestation) is a neglected tropical disease caused by penetration of female sand fleas,\n                      <jats:italic>Tunga penetrans<\/jats:italic>\n                      , in the skin. The disease inflicts immense pain and suffering on millions of people, particularly children, in Latin America, the Caribbean and sub-Saharan Africa. Currently, there is no standard treatment for tungiasis, and a simple, safe and effective tungiasis treatment option is required. Tea tree oil (TTO) has long been used as a parasiticidal agent against ectoparasites such as headlice, mites and fleas with proven safety and efficacy data. However, current data are insufficient to warrant a recommendation for its use in tungiasis. This trial aims to generate these data by comparing the safety and efficacy of a 5% (v\/w) TTO proprietary gel formulation with 0.05% (w\/v) potassium permanganate (KMnO\n                      <jats:sub>4<\/jats:sub>\n                      ) solution for tungiasis treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This trial is a randomised controlled trial (RCT) in primary schools (n=8) in South-Western Kenya. The study will include school children (n=88) aged 6\u201315 years with a confirmed diagnosis of tungiasis. The participants will be randomised in a 1:1 ratio to receive a 3-day two times a day treatment of either 5% TTO gel or 0.05% KMnO\n                      <jats:sub>4<\/jats:sub>\n                      solution. Two viable embedded sandflea lesions per participant will be targeted and the viability of these lesions will be followed throughout the study using a digital handheld microscope. The primary outcome is the proportion of observed viable embedded sand fleas that have lost viability (non-viable lesions) by day 10 (9 days after first treatment). Secondary outcomes include improvement in acute tungiasis morbidities assessed using a validated severity score for tungiasis, safety assessed through adverse events and product acceptability assessed by interviewing the participants to rate the treatment in terms of effectiveness, side effects, convenience, suitability and overall satisfaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial protocol has been reviewed and approved by the University of Canberra Human Research Ethics Committee (HREC-2019-2114). The findings of the study will be presented at scientific conferences and published in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>Australian New Zealand Clinical Trials Registry (ACTRN12619001610123); PACTR202003651095100 and U1111-1243-2294.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-047380","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T14:06:06Z","timestamp":1627567566000},"page":"e047380","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trial"],"prefix":"10.1136","volume":"11","author":[{"given":"Solomon","family":"Abrha","sequence":"first","affiliation":[{"name":"Pharmacy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia"},{"name":"Department of Pharmaceutics, Mekelle University, Mekelle, Tigray, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia K","family":"Christenson","sequence":"additional","affiliation":[{"name":"Pharmacy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"McEwen","sequence":"additional","affiliation":[{"name":"Pharmacy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-2330","authenticated-orcid":false,"given":"Wubshet","family":"Tesfaye","sequence":"additional","affiliation":[{"name":"Pharmacy, Health Research Institute, University of Canberra, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Vaz Nery","sequence":"additional","affiliation":[{"name":"The Public Health Interventions Research Program, The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen Y","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[{"name":"Public Health, Burnet Institute International Health Research Group, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Kosari","sequence":"additional","affiliation":[{"name":"Pharmacy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Kigen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Moi University School of Medicine, Eldoret, Central, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Carroll","sequence":"additional","affiliation":[{"name":"Pharmacy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia"},{"name":"Global School Partners, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorg","family":"Heukelbach","sequence":"additional","affiliation":[{"name":"Department of Community Health, Federal University of Cear\u00e1, Fortaleza, Brazil, Fortaleza, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Feldmeier","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection Immunology, Campus Benjamin Franklin, Charit\u00e9 University Medicine, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bartholomaeus","sequence":"additional","affiliation":[{"name":"Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Daniel","sequence":"additional","affiliation":[{"name":"Centre for Research and Action in Public Health, Health Research Institute, University of Canberra, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-3882","authenticated-orcid":false,"given":"Gregory M","family":"Peterson","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0699-788X","authenticated-orcid":false,"given":"Jackson","family":"Thomas","sequence":"additional","affiliation":[{"name":"Pharmacy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"2025120600405865000_11.7.e047380.1","unstructured":"WHO\/Department of control of neglected tropical diseases . Recognizing neglected tropical diseases through changes on the skin: A training guide for front-line health workers [internet]. Geneva, Swizerland: WHO; 2018 [cited 2018 June 1]. Available: http:\/\/www.who.int\/neglected_diseases\/resources\/9789241513531\/en\/ [Accessed 9 Oct 2018]."},{"key":"2025120600405865000_11.7.e047380.2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00716.x"},{"key":"2025120600405865000_11.7.e047380.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2020.01.004"},{"key":"2025120600405865000_11.7.e047380.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-003-0877-7"},{"key":"2025120600405865000_11.7.e047380.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(02)00133-X"},{"key":"2025120600405865000_11.7.e047380.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03245.x"},{"key":"2025120600405865000_11.7.e047380.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-004-1197-2"},{"key":"2025120600405865000_11.7.e047380.8","unstructured":"WHO . Scabies and other ectoparasites [internet]. Geneva, Switzerland: WHO, 2020. Available: https:\/\/www.who.int\/neglected_diseases\/diseases\/scabies-and-other-ectoparasites\/en\/index1.html [Accessed 6 Feb 2020]."},{"key":"2025120600405865000_11.7.e047380.9","unstructured":"Ministry of Health . National policy guidelines on prevention and control of jigger infestations [internet]. Nairobi, Kenya: Division of Environmental Health; 2014 [cited 2014 January 1]. Available: http:\/\/guidelines.health.go.ke\/#\/category\/12\/95\/meta [Accessed 3 Oct 2018]."},{"key":"2025120600405865000_11.7.e047380.10","unstructured":"Ministry of Health . Press statement on new master plan to tackle targeted neglected tropical diseases [internet]. Uganda: Republic of Uganda Ministry of Health, 2012. Available: http:\/\/www.health.go.ug\/docs\/Press%20statement%20on%20NTDs.pdf [Accessed 2 Oct 2018]."},{"key":"2025120600405865000_11.7.e047380.11","doi-asserted-by":"publisher","DOI":"10.3201\/eid0908.030041"},{"key":"2025120600405865000_11.7.e047380.12","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1725-4"},{"key":"2025120600405865000_11.7.e047380.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2002.00904.x"},{"key":"2025120600405865000_11.7.e047380.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005901"},{"key":"2025120600405865000_11.7.e047380.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03280.x"},{"key":"2025120600405865000_11.7.e047380.16","first-page":"128","article-title":"Impact of tungiasis on acquisition of basic education among children aged 5-14 years in Murang\u2019a County, Kenya","volume":"2","author":"Josephine","year":"2015","journal-title":"Int J Innov Res Sci Eng Technol"},{"key":"2025120600405865000_11.7.e047380.17","first-page":"151","article-title":"Quantifying burden of disease caused by tungiasis using disability adjusted life years metric among the children aged 5-14 years in Murang\u2032 a County, Kenya","volume":"2","author":"Josephine","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"2025120600405865000_11.7.e047380.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005939"},{"key":"2025120600405865000_11.7.e047380.19","doi-asserted-by":"crossref","unstructured":"Elson L , Fillinger U , Feldmeier H . Tungiasis. In: Tyring SK , Lupi O , Hengge UR , eds. Tropical dermatology. 2nd edn. UK: Elsevier BV, 2017: 401\u20134.","DOI":"10.1016\/B978-0-323-29634-2.00032-8"},{"key":"2025120600405865000_11.7.e047380.20","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1981.01650030003001","article-title":"Generalized Tungiasis treated with thiabendazole","volume":"117","author":"Cardoso","year":"1981","journal-title":"Arch Dermatol"},{"key":"2025120600405865000_11.7.e047380.21","first-page":"416","article-title":"Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasites","volume":"54","author":"Heukelbach","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"2025120600405865000_11.7.e047380.22","first-page":"88","article-title":"Infestation of Tunga penetrans in villages near Zomba Central Hospital","volume":"25","author":"Mitchell","year":"2013","journal-title":"Malawi Med J"},{"key":"2025120600405865000_11.7.e047380.23","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30853-7","article-title":"Clinical interventions for tungiasis (sand flea disease): a systematic review","author":"Abrha","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025120600405865000_11.7.e047380.24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00034983.1982.11687508","article-title":"Treatment of human tungiasis with niridazole (ambilhar) a double-blind placebo-controlled trial","volume":"76","author":"Ade-Serrano","year":"1982","journal-title":"Ann Trop Med Parasitol"},{"key":"2025120600405865000_11.7.e047380.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003058"},{"key":"2025120600405865000_11.7.e047380.26","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-017-0046-9"},{"key":"2025120600405865000_11.7.e047380.27","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762004000800015"},{"key":"2025120600405865000_11.7.e047380.28","doi-asserted-by":"publisher","DOI":"10.1179\/000349803225002408"},{"key":"2025120600405865000_11.7.e047380.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000879"},{"key":"2025120600405865000_11.7.e047380.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002426"},{"key":"2025120600405865000_11.7.e047380.31","doi-asserted-by":"crossref","first-page":"e0007822","DOI":"10.1371\/journal.pntd.0007822","article-title":"Efficacy of a mixture of neem seed oil (Azadirachta indica) and coconut oil (Cocos nucifera) for topical treatment of tungiasis. A randomized controlled, proof-of-principle study","volume":"13","author":"Elson","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2025120600405865000_11.7.e047380.32","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed2030033","article-title":"Control of Tungiasis in absence of a roadmap: Grassroots and global approaches","volume":"2","author":"Elson","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"2025120600405865000_11.7.e047380.33","first-page":"278","article-title":"The potential risk of HIV infection and transmission of other blood-borne pathogens through the sharing of needles and pins among people infested with jiggers in Kenya","volume":"4","author":"Kamau","year":"2014","journal-title":"Int J Med Sci Public Health"},{"key":"2025120600405865000_11.7.e047380.34","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.418"},{"key":"2025120600405865000_11.7.e047380.35","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.1.50-62.2006"},{"key":"2025120600405865000_11.7.e047380.36","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0515"},{"key":"2025120600405865000_11.7.e047380.37","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1763"},{"key":"2025120600405865000_11.7.e047380.38","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199809000-00010"},{"key":"2025120600405865000_11.7.e047380.39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-4632.2012.05654.x","article-title":"A review of applications of tea tree oil in dermatology","volume":"52","author":"Pazyar","year":"2013","journal-title":"Int J Dermatol"},{"key":"2025120600405865000_11.7.e047380.40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetpar.2011.08.017","article-title":"Insecticidal and repellent effects of tea tree (Melaleuca alternifolia) oil against Lucilia cuprina","volume":"184","author":"Callander","year":"2012","journal-title":"Vet Parasitol"},{"key":"2025120600405865000_11.7.e047380.41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vetpar.2016.06.007","article-title":"Repellent effects of Melaleuca alternifolia (tea tree) oil against cattle tick larvae (Rhipicephalus australis) when formulated as emulsions and in \u03b2-cyclodextrin inclusion complexes","volume":"225","author":"Yim","year":"2016","journal-title":"Vet Parasitol"},{"key":"2025120600405865000_11.7.e047380.42","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.5.563"},{"key":"2025120600405865000_11.7.e047380.43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clae.2017.10.012","article-title":"The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis","volume":"41","author":"Murphy","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"key":"2025120600405865000_11.7.e047380.44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025120600405865000_11.7.e047380.45","unstructured":"Global School Parteners . GSP-helping the world meet the sustainable development goals: Global School Parteners; 2019 [updated June, 2018]. Available: https:\/\/www.globalschoolpartners.org.au [Accessed 26 Feb 2019]."},{"key":"2025120600405865000_11.7.e047380.46","unstructured":"Ahadi Kenya Trust . The jigger menace in Kenya report [internet] Nairobi, Kenya: Ahadi Kenya Trust; 2011 [Vol. 2]. Available: http:\/\/www.jigger-ahadi.org\/index.html [Accessed 2 Oct 2018]."},{"key":"2025120600405865000_11.7.e047380.47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.2002.67.214","article-title":"Ectopic localization of tungiasis","volume":"67","author":"Heukelbach","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"2025120600405865000_11.7.e047380.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-002-0817-y"},{"key":"2025120600405865000_11.7.e047380.49","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3373-5"},{"key":"2025120600405865000_11.7.e047380.50","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3855\/jidc.4324","article-title":"Tungiasis in northern Tanzania: a clinical report from Qameyu village, Babati district, Manyara region","volume":"8","author":"Dassoni","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"2025120600405865000_11.7.e047380.51","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-006-0348-z"},{"key":"2025120600405865000_11.7.e047380.52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/BCR.0b013e3182372bfa","article-title":"Itch assessment scale for the pediatric burn survivor","volume":"33","author":"Morris","year":"2012","journal-title":"J Burn Care Res"},{"key":"2025120600405865000_11.7.e047380.53","unstructured":"US Department of Health and Human Services . Common terminology criteria for adverse events (CTCAE). In: National Institutes of health NCI. USA: National Institutes of Health, National Cancer Institute, 2017."},{"key":"2025120600405865000_11.7.e047380.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.004"},{"key":"2025120600405865000_11.7.e047380.55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The International Conference on harmonization good clinical practice guideline","volume":"6","author":"Dixon","year":"1999","journal-title":"Quality Assurance"},{"key":"2025120600405865000_11.7.e047380.56","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) . ICH harmonised guideline: integrated addendum to ICH E6(R1): Guideline for good clinical practice E6(R2) [internet]. Geneva, Switzerland: ICH, 2016. Available: https:\/\/www.ich.org\/page\/efficacy-guidelines [Accessed 19 Feb 2020]."},{"key":"2025120600405865000_11.7.e047380.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2005.09.001"},{"key":"2025120600405865000_11.7.e047380.58","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(00)90830-2"},{"key":"2025120600405865000_11.7.e047380.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2004.01.008"},{"key":"2025120600405865000_11.7.e047380.60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0378-6323.30646","article-title":"The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study","volume":"73","author":"Enshaieh","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2025120600405865000_11.7.e047380.61","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.122734"},{"key":"2025120600405865000_11.7.e047380.62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1999.00396.x"},{"key":"2025120600405865000_11.7.e047380.63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1440-0960.1992.tb00103.x","article-title":"Tea tree oil in the treatment of tinea pedis","volume":"33","author":"Tong","year":"1992","journal-title":"Australas J Dermatol"},{"key":"2025120600405865000_11.7.e047380.64","first-page":"7","article-title":"A randomized controlled trial of topical tea tree preparation for MRSA colonized wounds","volume":"1","author":"RLP","year":"2014","journal-title":"Int J Nurs Sci"},{"key":"2025120600405865000_11.7.e047380.65","first-page":"349","article-title":"Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of molluscum contagiosum in children","volume":"11","author":"Markum","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"2025120600405865000_11.7.e047380.66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000078694","article-title":"Predictive testing for irritancy and allergenicity of tea tree oil in normal human subjects","volume":"2","author":"Aspres","year":"2003","journal-title":"Exogenous Dermatology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-047380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:41:15Z","timestamp":1765010475000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-047380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":66,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,29]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjopen-2020-047380"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-047380","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}